Department of Ultrasonography, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, People's Republic of China.
Department of Nephrology, Zhongshan Hospital of Traditional Chinese Medicine, Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, People's Republic of China.
Sci Rep. 2019 Aug 15;9(1):11921. doi: 10.1038/s41598-019-48488-4.
Radiomics reflects the texture and morphological features of tumours by quantitatively analysing the grey values of medical images. We aim to develop a nomogram incorporating radiomics and the Breast Imaging Reporting and Data System (BI-RADS) for predicting breast cancer in BI-RADS ultrasound (US) category 4 or 5 lesions. From January 2017 to August 2018, a total of 315 pathologically proven breast lesions were included. Patients from the study population were divided into a training group (n = 211) and a validation group (n = 104) according to a cut-off date of March 1, 2018. Each lesion was assigned a category (4A, 4B, 4C or 5) according to the second edition of the American College of Radiology (ACR) BI-RADS US. A radiomics score was generated from the US image. A nomogram was developed based on the results of multivariate regression analysis from the training group. Discrimination, calibration and clinical usefulness of the nomogram for predicting breast cancer were assessed in the validation group. The radiomics score included 9 selected radiomics features. The radiomics score and BI-RADS category were independently associated with breast malignancy. The nomogram incorporating the radiomics score and BI-RADS category showed better discrimination (area under the receiver operating characteristic curve [AUC]: 0.928; 95% confidence interval [CI]: 0.876, 0.980) between malignant and benign lesions than either the radiomics score (P = 0.029) or BI-RADS category (P = 0.011). The nomogram demonstrated good calibration and clinical usefulness. In conclusion, the nomogram combining the radiomics score and BI-RADS category is potentially useful for predicting breast malignancy in BI-RADS US category 4 or 5 lesions.
放射组学通过对医学图像的灰度值进行定量分析来反映肿瘤的纹理和形态特征。我们旨在开发一个结合放射组学和乳腺影像报告和数据系统(BI-RADS)的列线图,用于预测 BI-RADS 超声(US)类别 4 或 5 病变中的乳腺癌。 2017 年 1 月至 2018 年 8 月,共纳入 315 例经病理证实的乳腺病变患者。根据 2018 年 3 月 1 日的截止日期,将研究人群中的患者分为训练组(n=211)和验证组(n=104)。根据美国放射学院(ACR)BI-RADS US 的第二版,为每个病变分配一个类别(4A、4B、4C 或 5)。从 US 图像生成放射组学评分。基于训练组多变量回归分析的结果,开发了一个列线图。在验证组中评估了预测乳腺癌的列线图的区分度、校准度和临床实用性。放射组学评分包括 9 个选定的放射组学特征。放射组学评分和 BI-RADS 类别与乳腺癌的恶性程度独立相关。纳入放射组学评分和 BI-RADS 类别的列线图在良恶性病变之间的区分度(接受者操作特征曲线下面积 [AUC]:0.928;95%置信区间 [CI]:0.876,0.980)优于放射组学评分(P=0.029)或 BI-RADS 类别(P=0.011)。该列线图具有良好的校准度和临床实用性。总之,该列线图结合放射组学评分和 BI-RADS 类别,可用于预测 BI-RADS US 类别 4 或 5 病变中的乳腺癌。